Perimeter Medical Imaging’s Trial Success Sparks Optimism

Perimeter Medical Imaging AI (TSE:PINK) has released an update.

Perimeter Medical Imaging AI has announced positive results from a clinical trial for its B-Series OCT system with ImgAssist AI 2.0, showing a significant reduction in residual cancer during breast-conserving surgeries compared to standard methods. This breakthrough could potentially lower reoperation rates and improve patient experiences, setting the stage for FDA approval in early 2025.

For further insights into TSE:PINK stock, check out TipRanks’ Stock Analysis page.